Grandfield & Dodd’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.63M Buy
76,460
+1,301
+2% +$125K 0.37% 54
2025
Q4
$7.22M Sell
75,159
-8,520
-10% -$828K 0.41% 54
2025
Q3
$7.97M Sell
83,679
-3,777
-4% -$347K 0.45% 51
2025
Q2
$7.62M Sell
87,456
-6,912
-7% -$586K 0.45% 51
2025
Q1
$8.48M Sell
94,368
-7,727
-8% -$691K 0.53% 50
2024
Q4
$8.16M Sell
102,095
-10,614
-9% -$919K 0.5% 51
2024
Q3
$10.1M Sell
112,709
-22,674
-17% -$1.91M 0.6% 50
2024
Q2
$10.7M Sell
135,383
-31,084
-19% -$2.55M 0.67% 49
2024
Q1
$14.5M Sell
166,467
-38,661
-19% -$3.3M 0.92% 41
2023
Q4
$16.9M Sell
205,128
-17,835
-8% -$1.36M 1.17% 36
2023
Q3
$17.5M Buy
222,963
+535
+0.2% +$44.8K 1.28% 32
2023
Q2
$19.6M Sell
222,428
-2,744
-1% -$236K 1.37% 30
2023
Q1
$18.2M Buy
225,172
+2,799
+1% +$228K 1.27% 31
2022
Q4
$17.3M Buy
222,373
+3,515
+2% +$285K 1.26% 35
2022
Q3
$17.7M Sell
218,858
-1,831
-0.8% -$165K 1.44% 29
2022
Q2
$19.8M Buy
220,689
+3,540
+2% +$359K 1.56% 25
2022
Q1
$24.1M Buy
217,149
+1,228
+0.6% +$130K 1.63% 22
2021
Q4
$22.3M Buy
215,921
+2,587
+1% +$300K 1.44% 28
2021
Q3
$26.7M Sell
213,334
-1,843
-0.9% -$239K 1.87% 16
2021
Q2
$26.7M Buy
215,177
+2,783
+1% +$349K 1.85% 17
2021
Q1
$25.1M Buy
212,394
+820
+0.4% +$96.1K 1.88% 18
2020
Q4
$24.8M Buy
211,574
+1,899
+0.9% +$209K 1.94% 18
2020
Q3
$21.8M Buy
209,675
+2,729
+1% +$274K 1.96% 16
2020
Q2
$19M Sell
206,946
-912
-0.4% -$87.5K 1.84% 17
2020
Q1
$18.7M Sell
207,858
-9,435
-4% -$1M 2.21% 12
2019
Q4
$24.7M Buy
217,293
+8,745
+4% +$960K 2.25% 11
2019
Q3
$22.7M Buy
208,548
+683
+0.3% +$71.3K 2.23% 12
2019
Q2
$20.2M Buy
207,865
+1,411
+0.7% +$129K 2% 16
2019
Q1
$18.8M Buy
206,454
+1,736
+0.8% +$155K 1.96% 16
2018
Q4
$18.6M Sell
204,718
-1,055
-0.5% -$98.6K 2.2% 11
2018
Q3
$20.2M Sell
205,773
-895
-0.4% -$82.7K 2.09% 11
2018
Q2
$17.7M Buy
206,668
+5
+0% +$418 1.94% 15
2018
Q1
$16.6M Sell
206,663
-2,345
-1% -$193K 1.85% 17
2017
Q4
$16.9M Sell
209,008
-2,090
-1% -$167K 1.8% 19
2017
Q3
$16.4M Buy
211,098
+3,336
+2% +$277K 1.84% 18
2017
Q2
$18.4M Sell
207,762
-7,130
-3% -$601K 2.18% 11
2017
Q1
$17.3M Sell
214,892
-10,636
-5% -$831K 2.14% 11
2016
Q4
$16.1M Sell
225,528
-180
-0.1% -$14.1K 2.08% 11
2016
Q3
$19.5M Sell
225,708
-5,207
-2% -$454K 2.56% 9
2016
Q2
$20M Sell
230,915
-2,146
-0.9% -$174K 2.8% 6
2016
Q1
$17.5M Buy
233,061
+662
+0.3% +$49.9K 2.53% 8
2015
Q4
$17.9M Sell
232,399
-6,718
-3% -$506K 2.72% 6
2015
Q3
$16M Buy
239,117
+1,294
+0.5% +$95.3K 2.68% 7
2015
Q2
$17.6M Sell
237,823
-2,035
-0.8% -$155K 2.7% 7
2015
Q1
$18.7M Buy
239,858
+6,609
+3% +$501K 2.86% 5
2014
Q4
$16.8M Buy
233,249
+4,167
+2% +$289K 2.6% 5
2014
Q3
$14.2M Buy
229,082
+698
+0.3% +$44.4K 2.23% 10
2014
Q2
$14.6M Buy
228,384
+3,575
+2% +$217K 2.2% 8
2014
Q1
$13.8M Buy
224,809
+1,505
+0.7% +$87.7K 2.17% 9
2013
Q4
$12.8M Buy
223,304
+655
+0.3% +$37.1K 2.08% 11
2013
Q3
$11.9M Sell
222,649
-2,770
-1% -$149K 2.11% 11
2013
Q2
$11.6M Buy
+225,419
New +$11.1M 2.2% 10

Other funds holding MDT

Grandfield & Dodd's MDT Position: Q1 2026 in Review

Grandfield & Dodd increased its Medtronic (MDT) stake by 1.7% in Q1 2026, buying an estimated $125K and bringing the position to 76,460 shares worth $6.63M. The position accounts for 0.37% of the portfolio, ranked #54.

Grandfield & Dodd first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $26.7M in Q3 2021. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Grandfield & Dodd held 76,460 shares of Medtronic worth $6.63M as of Q1 2026.
  • Grandfield & Dodd bought 1,301 Medtronic shares in Q1 2026, an estimated $125K.
  • Medtronic made up 0.37% of Grandfield & Dodd's portfolio in Q1 2026, its #54 holding.
  • Grandfield & Dodd first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Grandfield & Dodd's Medtronic position peaked at $26.7M in Q3 2021.
  • 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Grandfield & Dodd's 13F filing for Q1 2026, filed 7 May 2026.